Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02349724 | A Clinical Research of CAR T Cells Targeting CEA Positive Cancer | unknown | Phase 1 | 75 | Southwest Hospital, ChinaOTHER | 1 | Apr 25, 2017 | clinicaltrials |
| NCT02441972 | Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics | unknown | Phase 1 | 200 | Wuxi No. 4 People's HospitalOTHER | 1 | Mar 10, 2017 | clinicaltrials |
| NCT02396108 |
| Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer |
| unknown |
| Phase 1 / Phase 2 |
| 55 |
| National University Hospital, SingaporeOTHER |
| 1 |
| Feb 3, 2017 |
| clinicaltrials |
| NCT00049244 | BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer | unknown | Phase 1 | — | R-PharmINDUSTRY | 1 | Jan 30, 2017 | clinicaltrials |
| NCT01304797 | Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer | unknown | Phase 1 | 75 | Merrimack PharmaceuticalsINDUSTRY | 1 | Jan 6, 2017 | clinicaltrials |
| NCT02970786 | Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans | unknown | Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Nov 22, 2016 | clinicaltrials |
| NCT02886897 | A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors | unknown | Phase 1 / Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Sep 1, 2016 | clinicaltrials |
| NCT02457650 | T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies | unknown | Phase 1 | 36 | Shenzhen Second People's HospitalOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT02030561 | NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer | unknown | Phase 1 / Phase 2 | 29 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT02225015 | Cancer Prevention in Women With a BRCA Mutation | unknown | Phase 1 | 300 | Women's College HospitalOTHER | 1 | Jun 9, 2016 | clinicaltrials |
| NCT02749019 | Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients | unknown | Phase 1 | 40 | Peking Union Medical College HospitalOTHER | 1 | Apr 22, 2016 | clinicaltrials |
| NCT01016886 | Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research(MANTICORE) | unknown | Phase 1 / Phase 2 | 99 | University of AlbertaOTHER | 1 | Feb 9, 2016 | clinicaltrials |
| NCT02616848 | Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers | unknown | Phase 1 | 1 | Istituti Ospitalieri di CremonaOTHER | 1 | Nov 30, 2015 | clinicaltrials |
| NCT02580747 | Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso | unknown | Phase 1 | 20 | Chinese PLA General HospitalOTHER | 1 | Oct 20, 2015 | clinicaltrials |
| NCT02294565 | VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer | unknown | Phase 1 / Phase 2 | 147 | Vestan, Inc.INDUSTRY | 1 | Jul 27, 2015 | clinicaltrials |
| NCT01764087 | A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | May 18, 2015 | clinicaltrials |
| NCT01462903 | A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors | unknown | Phase 1 | 20 | Sun Yat-sen UniversityOTHER | 1 | Nov 24, 2014 | clinicaltrials |
| NCT01159405 | The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer | unknown | Phase 1 | 9 | SeeCure LLCINDUSTRY | 1 | Jul 30, 2014 | clinicaltrials |
| NCT00004207 | Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer | unknown | Phase 1 | — | University of LeicesterOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00002627 | Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer | unknown | Phase 1 / Phase 2 | 30 | St. Louis UniversityOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00002628 | Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 50 | St. Louis UniversityOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00002780 | Biological Therapy in Treating Women With Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 60 | St. Luke's Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00024063 | SU006668 in Treating Patients With Advanced Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00022425 | Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy | unknown | Phase 1 | — | The Cleveland ClinicOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00416130 | Clinical Trial of SAHA in Patients With Breast Cancer | unknown | Phase 1 / Phase 2 | 49 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00066547 | Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy | unknown | Phase 1 / Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00002465 | High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma | unknown | Phase 1 / Phase 2 | — | St. Vincent Medical Center - Los AngelesOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00002616 | Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer | unknown | Phase 1 | 36 | University of Illinois at ChicagoOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00009763 | Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer | unknown | Phase 1 | — | University of California, DavisOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00003412 | Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation | unknown | Phase 1 | 35 | Beth Israel Deaconess Medical CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT01931943 | A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer | unknown | Phase 1 | 24 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 30, 2013 | clinicaltrials |
| NCT00931450 | Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer | unknown | Phase 1 / Phase 2 | 70 | Institut Català d'OncologiaOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00003920 | Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer | unknown | Phase 1 | 18 | University of California, DavisOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT01880385 | Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer(Beva) | unknown | Phase 1 | 30 | Association Tunisienne de lutte Contre le CancerOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT01016574 | Evaluating the Adequacy of Giro-Couch to Support Prone Breast Boost Irradiation Using IMRT Technique With IGRT.(IN902) | unknown | Phase 1 | 15 | Azimuth Therapy Ltd.INDUSTRY | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00891280 | Dose-escalation Study of Oral CX-4945 | unknown | Phase 1 | 55 | Cylene PharmaceuticalsINDUSTRY | 1 | Jun 15, 2011 | clinicaltrials |
| NCT00879489 | Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 24 | Quantum Immunologics, Inc.OTHER | 1 | Feb 25, 2011 | clinicaltrials |
| NCT01278810 | Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients | unknown | Phase 1 | 30 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 28, 2011 | clinicaltrials |
| NCT00930475 | Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 54 | Charite University, Berlin, GermanyOTHER | 1 | Jan 26, 2011 | clinicaltrials |
| NCT00367250 | Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer | unknown | Phase 1 | 32 | Medical University of ViennaOTHER | 1 | Sep 28, 2010 | clinicaltrials |
| NCT00915369 | A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer | unknown | Phase 1 | 24 | Fresenius Kabi Oncology Ltd.INDUSTRY | 1 | Feb 8, 2010 | clinicaltrials |
| NCT01022333 | The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers | unknown | Phase 1 | 300 | Women's College HospitalOTHER | 1 | Dec 1, 2009 | clinicaltrials |
| NCT00715832 | A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer | unknown | Phase 1 | 25 | Southern Cancer CenterOTHER | 1 | Aug 26, 2009 | clinicaltrials |
| NCT00764972 | Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 36 | McGill UniversityOTHER | 1 | Oct 21, 2008 | clinicaltrials |
| NCT00555516 | A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy | unknown | Phase 1 / Phase 2 | 60 | Tri-Service General Hospital (TSGH)OTHER | 1 | Nov 8, 2007 | clinicaltrials |
| NCT00419900 | Use of Hair to Diagnose the Presence of Breast Cancer | unknown | Phase 1 / Phase 2 | 2,000 | Fermiscan LtdINDUSTRY | 1 | Jan 9, 2007 | clinicaltrials |
| NCT00337064 | Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women | unknown | Phase 1 / Phase 2 | 75 | University of VermontOTHER | 1 | Jun 15, 2006 | clinicaltrials |
| NCT00040430 | Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer | unknown | Phase 1 | — | CopharosINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Apr 25, 2017source: clinicaltrials